COMBINE launches “all-in-one” coordinated assessment pilot

The European Commission, participating Member States, and the European Medicines Agency (EMA) have announced the launch of the first phase of the COMBINE Project 1 pilot.

The COMBINE project was launched by the European Commission in June 2023, with the goal of simplifying and harmonizing regulatory processes for combined studies to ensure timely access to innovative therapies for patients across Europe.

On 13 June 2025, the first phase of the COMBINE Project 1 pilot was launched. It aims to explore the feasibility of a coordinated assessment procedure using the Clinical Trials Information System (CTIS) for applications that involve a multinational clinical trial of an investigational medicinal product combined with an interventional clinical performance study of an in vitro diagnostic or companion diagnostic medical device, run by the same sponsor. 

The ‘all-in-one’ coordinated procedure is expected to:

  • streamline the authorisation process
  • reduce administrative burden for sponsors
  • accelerate patient access to innovative treatments

Sponsors are invited to express their interest by submitting a completed form and a synopsis of proposed combined study via Eudralink to EUcombinepilot@ccmo.nl by 31 August 2025.

Find out more on the European Commission website here.

Expert regulatory advice

The Boyds Regulatory Affairs team is closely following developments in this area. If you would like to discuss the COMBINE project or would like any advice, please get in touch and a member of our team will be happy to help.

Facebook
Twitter
LinkedIn